ARWR Arrowhead Pharmaceuticals, Inc.
$82.85▲ +0.11%
Healthcare
Other
After hours
$82.79▼ -0.07%
Sep 11, 7:30 PM ET
Volume 1.34M
Avg Volume (10D) 1.50M
Key Metrics & Fundamentals
Market Cap
$11.70B
P/E Ratio
–
Div Yield
–%
52W Range
28.12 - 95.49
% vs 50 MA
-1.66%
% vs 200 MA
15.05%
RSI-14
43.7
MACD Histogram
-0.6300
Beta (1Y vs SPY)
1.54
Free Cash Flow
-$181.32M
Gross Rev
$75.25M
Gross Profit
$75.25M
EBITDA
-$147.68M
COGS
–
Operating Exp
$245.35M
Operating Income
-$170.09M
EBIT
-$170.09M
Pretax Income
-$178.91M
Net Income
-$194.28M
EPS (Diluted)
-1.36
Price & Volume History
Loading chart…
Recent News

ARWR: SHASTA-3 and SHASTA-4 Data Presented at ESC 2026
Zacks Small Cap Research · Sep 8, 2026 11:07 AM
Citigroup Initiates Arrowhead Pharmaceuticals at Buy With $108 Price Target
MT Newswires · Sep 8, 2026 10:13 AM

Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million
Motley Fool · Sep 6, 2026 10:15 PM

Arrowhead (ARWR) Reported a 78% Lower Pancreatitis Event Rate With Plozasiran. Does the Absolute Benefit Support a Broader Label?
Insider Monkey · Sep 4, 2026 4:15 PM

This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
Barrons.com · Sep 4, 2026 4:13 PM

Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
Business Wire · Sep 3, 2026 11:30 AM

Is Arrowhead Pharmaceuticals (ARWR) Undervalued As SHASTA 3 And SHASTA 4 Data Impress?
Simply Wall St. · Sep 1, 2026 11:09 AM

Arrowhead’s Plozasiran Cuts Triglycerides, Pancreatitis Risk in Phase 3 Trials
MarketBeat · Aug 31, 2026 3:02 PM
Arrowhead Pharmaceuticals' sHTG Therapy Could Get FDA Approval by Q2 2027, RBC Says
MT Newswires · Aug 31, 2026 2:48 PM
Sector Update: Healthcare Stocks Fall Premarket Monday
MT Newswires · Aug 31, 2026 1:19 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARWR's money flow as a full page
Social Sentiment
Avg +0.60 · 2 posts
DiscussionPriceTargetGreat start to the day! ARWR 🚀
r/wallstreetbets · Jan 6, 2026
The enthusiastic language ('🚀') and questions about price targets indicate positive sentiment towards the stock.
positive
+0.60
DDNewsTradeGood year for gambling on small cap biotech! ARWR is 🚀.
r/wallstreetbets · Dec 23, 2025
The post expresses enthusiasm about ARWR's performance, suggesting a bullish sentiment.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.